Interested in Making an Extra $10,000 Every month for Your Practice?
Modern Health Care Professional


Treating ADD/ADHD More Effectively

Dr. Bradley Bush discusses conditions that are common in children, like ADD and ADHD. He talks about how working with psychiatrists and monitoring certain neurotransmitters might lead to a more effective way of treating the conditions. read more…

Case Study: The Effectiveness of a Dietary Supplement Regimen in Reducing Igg-Mediated Food Sensitivity in ADHD

Barry W. Ritz, MS, Richard S. Lord, PhD

Immunologic response to allergens varies depending on the level of exposure. Low-exposure antigens, such as house dust and pollen, trigger immunoglobulin E (IgE) antibody recognition, which results in histamine release and a cascade of immunologic events designed to sequester and destroy the antigen. On some occasions, these events, cumulatively termed a type I reaction, can escalate to the severity of anaphylaxis and death. In contrast, relatively high-exposure antigens, including molds and certain occupational exposures and food proteins that pass through a damaged mucosa, generally result in a mixture of immunoglobulin activity read more…

Syndrome of Allergy, Apraxia, and Malabsorption: Characterization of a Neurodevelopmental Phenotype That Responds to Omega 3 and Vitamin E Supplementation

Claudia R. Morris, MD; Marilyn C. Agin, MD

Accumulating evidence suggests that developmental disorders such as apraxia/dyspraxia (developmental coordination disorder), attention defi cit hyperactivity disorder (ADHD), dyslexia, and autism spectrum disorders (ASD) are conditions involving a defi ciency of long-chain polyunsaturated fatty acids (PUFAs).1-16 Studies demonstrating the importance of sufficient docosahexaenoic acid (DHA) for brain development17 have led to the routine addition of DHA to most commercially available infant formulas. Supplementation with omega 3 fi sh oil is a safe intervention4,18 that has led to improvements in behavior, motor skills, and language in many children affected by the aforementioned read more…

Alternative Treatments For Attention deficit/ Hyperactivity Disorder: Does Evidence Support Their Use?

Alan W. Brue, PhD, and Thomas D. Oakland, PhD

Attention-deficit/hyperactivity disorder (ADHD) is a treatable but incurable and complex condition. Children and adolescents predominantly are affected, with onset typically between ages 3 and 7 years.1 However, given the lifelong qualities of the condition, adults also exhibit ADHD symptoms. From 6% to 8% of school-aged children2—approximately 2 to 3 million—are affected in the United States.3 The disorder is more common in boys,4 with the male-to-female ratio ranging from 2-to-1 to 10-to-1. read more…

© 2017 Modern Healthcare Professional. All Rights Reserved.